Efforts to Increase Representation in Prostate Cancer Clinical Trials at Lyndon B. Johnson Hospital
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Video.
- Who it may be relevant to
- Registry conditions: Prostate Cancer. Basic parameters: from 18 years · Male.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
The main rationale underlying this study is that prostate cancer clinical trials are lacking representation from racial and ethnic minority groups. Study proposal aims to target barriers at the participant, investigator, and health system level through specific interventions to increase the percentage of participants from these backgrounds on cancer clinical trials.
Detailed description
Primary Objectives:
The study objective is to increase the number of participants on prostate cancer clinical trials at LBJ. Investigators will complete several objectives:
* To design a culturally tailored video highlighting participant narratives and determine its impact on participants' decision-making pertaining to joining a clinical trial * To conduct educational sessions with frontline oncology providers * To coordinate participant care through utilization of a nurse navigator * To evaluate the effectiveness of this multi-pronged intervention to increase enrollment onto two prostate cancer clinical trials and compare enrollment and one-year retention rates before and after the intervention
Interventions
- Other Video
Participants will watch a short video in clinic. Participants will complete the two validated scales before and after viewing the video.
Primary outcome measures
- Safety and Adverse Events (AEs) [Time frame: Through study completion; an average of 1 year]
Eligibility criteria
Inclusion criteria
These criteria include diagnosed prostate cancer patients receiving care at LBJ Hospital who
Are eligible for an open prostate cancer clinical trial at LBJ Hospital during the study period
Can provide informed consent.
Exclusion criteria
These criteria include prostate cancer patients receiving care at LBJ who are unable to participate due to a serious psychological or cognitive condition or have a medical condition that prevents participation in the trial.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Non-randomized
- Model
- Parallel assignment
- Masking
- Open label
- Primary purpose
- Health services research
Study locations
United States · 1 center
- The University of Texas M. D. Anderson Cancer Center — Houston
Identifiers
NCT: NCT07591701 · 2025-1431 · NCI-2025-09179